Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04131790 · ClinicalTrials.gov registry record · NA

Tele-BA for Home-Delivered Meals Clients

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
89
Enrollment target

NCT04131790: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT04131790 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04131790, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target

Study Summary

The purpose of this study to evaluate aging-service integrated, video-conference-based approaches to improve homebound seniors' social engagement and activities.

Primary Outcome

A 10-item self-report questionnaire used to measure an individual's satisfaction with social support using a Likert scale (3-point scale, where anchor labels are specified for each item). This scale consists of two subscales: 4-item social interaction (objective support) scale and 6-item satisfaction with social support (subjective support) subscale. Total scores are calculated by summing responses to items across all items; total scores range 10-30.

Interventions

  • BEHAVIORAL Tele-Behavioral Activation
  • BEHAVIORAL Tele-Friendly Visiting

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2017-06-16
Est. Completion 2020-09-01
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT04131790 record still lists

NCT04131790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Tele-Behavioral Activation is the first listed.

NCT04131790 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04131790 about?

NCT04131790 is a clinical study titled "Tele-BA for Home-Delivered Meals Clients". The purpose of this study to evaluate aging-service integrated, video-conference-based approaches to improve homebound seniors' social engagement and activities.

What is the current status of trial NCT04131790?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2017-06-16. Estimated completion is 2020-09-01.

What interventions are being tested in trial NCT04131790?

The interventions under investigation include: Tele-Behavioral Activation (BEHAVIORAL), Tele-Friendly Visiting (BEHAVIORAL).

Who is sponsoring clinical trial NCT04131790?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04131790's enrollment target sits among peer trials

89 972nd of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04131790, the US trial registry maintained by the National Library of Medicine. NCT04131790 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.